DISCUSSION ON THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND OSTEOARTHRITIS
Keywords:
Osteoarthritis, Metabolic syndrome, Adipocytokines, Macrophages, Intestinal floraAbstract
Osteoarthritis (OA) is a multifactorial degenerative joint disease, mainly involving changes in articular cartilage, subchondral bone, ligaments, joint capsule, synovium and periarticular structures. Its pathogenesis remains unclear. As my country's population ages, the incidence of OA is gradually increasing. At the same time, most elderly patients are accompanied by basic metabolic diseases such as hypertension and diabetes. Metabolic osteoarthritis has now been identified as a new subtype of OA. In addition to surgical treatment, palliative treatment is the first choice, but its effect is limited. Therefore, metabolic osteoarthritis imposes a heavy burden on society and individuals, especially elderly patients. This article mainly introduces the current research status of the relationship between metabolic syndrome and osteoarthritis, and provides reference for the exploration of related targeted therapies.References
[1] Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol, 2014, 10(7):437-441. DOI: 10.1038/nrrheum.2014.44.
[2] Pereira D, Peleteiro B, Araújo J. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage, 2011, 19(11):1270-1285. DOI: 10.1016/j.joca.2011.08.009.
[3] Wallace IJ, Worthington S, Felson DT. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U SA, 2017, 114(35):9332-9336. DOI: 10.1073/pnas.1703856114.
[4] Alberti KG, Eckel RH, Grundy SM. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009, 120(16):1640-1655. DOI: 10.1161/CIRCULATIONAHA.109.192644.
[5] Bortoluzzi A, Furini F, Scirè CA. Osteoarthritis and its management - Epidemiology, nutritional aspects and environmental factors. Autoimmun Rev, 2018, 17(11): 1097-1104. DOI: 10.1016/j.autrev.2018.06.002.
[6] Michalek RD, Rathmell JC. The metabolic life and times of a T-cell. Immunol Rev, 2010, 236:190-202. DOI: 10.1111/j.1600-065X.2010.00911.x.
[7] Mobasheri A, Rayman MP, Gualillo O. The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol, 2017, 13(5):302-311. DOI: 10.1038/nrrheum. 2017.50.
[8] Kolasinski SL, Neogi T, Hochberg MC. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken), 2020, 72(2):149-162. DOI:10.1002/acr.24131.
[9] Berenbaum F, Eymard F, Houard X. Osteoarthritis, inflammation and obesity. Curr Opin Rheumatol, 2013, 25(1):114-118. DOI: 10.1097/BOR.0b013e32835a9414.
[10] Engstr?m G, Gerhardsson de Verdier M, Rollof J. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage, 2009, 17(2):168-713. DOI: 10.1016/j.joca.2008.07.003.
[11] Vieira-Potter VJ. Inflammation and macrophage modulation in adipose tissues. Cell Microbiol, 2014, 16(10):1484-1492. DOI: 10.1111/cmi.12336.
[12] Francisco V, Ruiz-Fernández C, Pino J. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol, 2019, 165:196-206. DOI: 10.1016/j.bcp.2019.03.030.
[13] Xie C, Chen Q. Adipokines: new therapeutic target for osteoarthritis? Curr Rheumatol Rep, 2019, 21(12):71. DOI: 10.1007/s11926-019-0868-z.
[14] Sun Y, Xun K, Wang C. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther, 2009, 27(1):59-75. DOI: 10.1111/j.1755-5922.2008.00069.x.
[15] Liu M, Liu F. Regulation of adiponectin multimerization, signaling and function. Best Pract Res Clin Endocrinol Metab, 2014, 28(1):25-31. DOI: 10.1016/j.beem.2013.06.003.
[16] Kim ES, Im JA, Kim KC. Improved insulin sensitivity and adiponectin level after exercise training in obese korean youth. Obesity (Silver Spring), 2007, 15(12):3023-3030. DOI: 10.1038/oby.2007.360.
[17] Hu J, Cui W, Ding W. Globular adiponectin attenuated H2O2-induced apoptosis in rat chondrocytes by inducing autophagy through the AMPK/mTOR pathway. Cell Physiol Biochem, 2017, 43(1):367-382. DOI: 10.1159/000480416.
[18] Landgraeber S, Putz S, Schlattjan M. Adiponectin attenuates osteolysis in aseptic loosening of total hip replacements. Acta Biomater, 2014, 10(1):384-393. DOI: 10.1016/j.actbio.2013.08.031.
[19] Conde J, Gomez R, Bianco G. Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis, 2011, 70(3):551-559. DOI: 10.1136/ard.2010.132399.
[20] Li WC, Hsiao KY, Chen IC. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. Cardiovasc Diabetol, 2011, 10:36. DOI: 10.1186/1475-2840-10-36.
[21] Panchal SK, Poudyal H, Iyer A. High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol, 2011, 57(5): 611-624. DOI: 10.1097/FJC.0b013e31821b1379.
[22] Dumond H, Presle N, Terlain B. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum, 2003, 48(11):3118-3129. DOI: 10.1002/art.11303.
[23] Gómez R, Scotece M, Conde J. Adiponectin and leptin increase IL-8 production in human chondrocytes. Ann Rheum Dis, 2011, 70(11):2052-2054. DOI: 10.1136/ard.2010.145672.
[24] Abella V, Scotece M, Conde J. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers, 2015, 20(8):565-571. DOI: 10.3109/1354750X.2015.1123354.
[25] Jang Y, Lee JH, Wang Y. Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. Clin Exp Pharmacol Physiol, 2012, 39(2): 194-199. DOI: 10.1111/j.1440-1681.2011.05557.x.
[26] Dickson BM, Roelofs AJ, Rochford JJ. The burden of metabolic syndrome on osteoarthritic joints. Arthritis Res Ther, 2019, 21(1):289. DOI: 10.1186/s13075-019-2081-x.
[27] Blom AB, van Lent PL, Holthuysen AE. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage, 2004, 12(8):627-635. DOI: 10.1016/j.joca.2004.03.003.